Assessing the potential cost-effectiveness of retesting IHC0, IHC1+, or FISH-negative early stage breast cancer patients for HER2 status

M. Z. Gilcrease

Research output: Contribution to journal › Comment/debate › peer-review

ASJC Scopus subject areas

@article{f51f3022671647f3b9f70da59be2103b,

title = "Assessing the potential cost-effectiveness of retesting IHC0, IHC1+, or FISH-negative early stage breast cancer patients for HER2 status",

author = "Gilcrease, {M. Z.}",

year = "2014",

doi = "10.1016/j.breastdis.2014.01.010",

language = "English (US)",

volume = "25",

pages = "93--94",

journal = "Breast Diseases",

issn = "1043-321X",

publisher = "Academic Press Inc.",

number = "1",

}

TY - JOUR

T1 - Assessing the potential cost-effectiveness of retesting IHC0, IHC1+, or FISH-negative early stage breast cancer patients for HER2 status

AU - Gilcrease, M. Z.

PY - 2014

Y1 - 2014

UR - http://www.scopus.com/inward/record.url?scp=84896758591&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896758591&partnerID=8YFLogxK

U2 - 10.1016/j.breastdis.2014.01.010

DO - 10.1016/j.breastdis.2014.01.010

M3 - Comment/debate

AN - SCOPUS:84896758591

SN - 1043-321X

VL - 25

SP - 93

EP - 94

JO - Breast Diseases

JF - Breast Diseases

IS - 1

ER -